Speaking at Infection Week 2019 in Jönköping

Gradientech has been invited to hold a short lecture at the Infection Week & Microbiological Spring Meeting (14-17 May) in Jönköping. The presentation will focus on QuickMIC™, the IVD system that Gradientech is currently developing for ultra-rapid antibiotic susceptibility testing (AST).

For further information, please contact:
Sara Thorslund, PhD, CEO Gradientech
Tel: +46 736 29 35 80
sara.thorslund@gradientech.se

About Gradientech
Gradientech is a diagnostics company developing the in vitro diagnostic QuickMIC® system, a new platform for antibiotic susceptibility testing based on phenotypic bacterial growth analysis. The system is expected to become the most rapid solution for determining appropriate antibiotic treatment of sepsis patients. Rapid antibiotic susceptibility testing is vital for increasing sepsis patient survival, reducing healthcare costs and lowering the spread of antibiotic resistance. www.gradientech.se